AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(24 sites)

United States

Eastern Shore Research Institute, LLC, Fairhope, Alabama

University of Arizona Sarver Heart Center, Tucson, Arizona

John L. McClellan Memorial Veterans Hospital, Little Rock, Arkansas

BioSolutions Clinical Research Center, Imperial, California

Profound Research LLC, Pasadena, California